Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques.
Saved in:
| Title: | Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques. |
|---|---|
| Authors: | Van Rompay, Koen K. A.1,2 (AUTHOR) kkvanrompay@ucdavis.edu, Olstad, Katherine J.1,2 (AUTHOR), Sammak, Rebecca L.1 (AUTHOR), Dutra, Joseph3 (AUTHOR), Watanabe, Jennifer K.1 (AUTHOR), Usachenko, Jodie L.1 (AUTHOR), Immareddy, Ramya1 (AUTHOR), Verma, Anil4 (AUTHOR), Shaan Lakshmanappa, Yashavanth4 (AUTHOR), Schmidt, Brian A.4 (AUTHOR), Roh, Jamin W.4 (AUTHOR), Elizaldi, Sonny R.4 (AUTHOR), Allen, A. Mark1 (AUTHOR), Muecksch, Frauke5 (AUTHOR), Lorenzi, Julio C. C.6 (AUTHOR), Lockwood, Sarah1 (AUTHOR), Pollard, Rachel E.7 (AUTHOR), Yee, JoAnn L.1 (AUTHOR), Nham, Peter B.1 (AUTHOR), Ardeshir, Amir1 (AUTHOR) |
| Source: | PLoS Pathogens. 7/6/2021, Vol. 17 Issue 7, p1-22. 22p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15537366 |
|---|---|
| DOI: | 10.1371/journal.ppat.1009688 |
